Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review

Cancer is a metabolic disease and the solution of two metabolic equations: to produce energy with limited resources and to fulfill the biosynthetic needs of proliferating cells. Both equations are solved when glycolysis is uncoupled from oxidative phosphorylation in the tricarboxylic acid cycle, a process known as the glycolytic switch. This review addresses in a comprehensive manner the main molecular events accounting for high-rate glycolysis in cancer. It starts from modulation of the Pasteur Effect allowing short-term adaptation to hypoxia, highlights the key role exerted by the hypoxia-inducible transcription factor HIF-1 in long-term adaptation to hypoxia, and summarizes the current knowledge concerning the necessary involvement of aerobic glycolysis (the Warburg effect) in cancer cell proliferation. Based on the many observations positioning glycolysis as a central player in malignancy, the most advanced anticancer treatments targeting tumor glycolysis are briefly reviewed

Greenhouse gas inventory estimates for India

This article reports the greenhouse gas emissions of anthropogenic origin by sources and removals by sinks of India for 2007 prepared under the aegis of the Indian Network for Climate Change Assessment (INCCA) (note 1). The emission profile includes carbon dioxide (CO(2)), methane and nitrous oxide. It also includes the estimates of hydrofluorocarbons, perfluorocarbons and sulphur hexafluoride at the national level from various sectors, viz, energy, industrial process and product use, agriculture, land-use, land-use change and forestry (LULUCF), and waste. In 2007, emissions were of the order of 2008.67 Tg (note 2) of CO(2) equivalents without emissions from the LULUCF sector. Whereas with LULUCF the emissions were about 1831.65 Tg CO(2) equivalents. The energy sector accounted for 69% of the total emissions, the agriculture sector contributed 19% of the emissions, 9% of the emissions was from the industrial processes and product use, and only 3% of the emissions was attributable to the waste sector. The LULUCF sector on the whole was net sink category for CO(2). The study tracks the improvements made in inventory estimates at the national level through the years, in terms of the expanding coverage of sources, reducing uncertainties and inclusion of new methodologies, including some elements of future areas of work

Expression of the monocarboxylate transporter MCT1 is required for virus-specific mouse CD8+ T cell memory development.

peer reviewedLactate-proton symporter monocarboxylate transporter 1 (MCT1) facilitates lactic acid export from T cells. Here, we report that MCT1 is mandatory for the development of virus-specific CD8+ T cell memory. MCT1-deficient T cells were exposed to acute pneumovirus (pneumonia virus of mice, PVM) or persistent γ-herpesvirus (Murid herpesvirus 4, MuHV-4) infection. MCT1 was required for the expansion of virus-specific CD8+ T cells and the control of virus replication in the acute phase of infection. This situation prevented the subsequent development of virus-specific T cell memory, a necessary step in containing virus reactivation during γ-herpesvirus latency. Instead, persistent active infection drove virus-specific CD8+ T cells toward functional exhaustion, a phenotype typically seen in chronic viral infections. Mechanistically, MCT1 deficiency sequentially impaired lactic acid efflux from activated CD8+ T cells, caused an intracellular acidification inhibiting glycolysis, disrupted nucleotide synthesis in the upstream pentose phosphate pathway, and halted cell proliferation which, ultimately, promoted functional CD8+ T cell exhaustion instead of memory development. Taken together, our data demonstrate that MCT1 expression is mandatory for inducing T cell memory and controlling viral infection by CD8+ T cells